Schwab Emerging Markets ETF vs. iShares World ETF: Which International ETF Is the Better Buy for Investors?

This is mostly a factor-allocation signal, not a fundamental catalyst. URTH is the cleaner expression of quality/growth/low-drawdown exposure, while SCHE is a higher-beta, policy-sensitive value/dividend proxy; the fee gap matters far less than currency moves, rates, and China sentiment over any 3-6 month horizon. In practice, the market will reward whichever sleeve is getting incremental passive flows, and that remains skewed toward developed-market megacap tech unless the USD weakens materially.

Second-order winners are the AI/platform complex inside URTH: AAPL, MSFT, and NVDA benefit from the same concentration effect that makes the ETF look expensive on fees but cheap on risk-adjusted exposure. On the SCHE side, TSM is the cleanest beneficiary because it can be owned as a global semiconductor infrastructure name rather than a pure EM beta line item; BABA and TCEHY remain trapped under a heavier geopolitical and governance discount, so higher yield is really compensation for uncertainty rather than a standalone positive.

The contrarian miss is that investors may overfocus on expense ratio and underweight regime risk. If China stimulus gains traction, the USD rolls over, or global manufacturing PMI stabilizes, SCHE can outperform sharply from a low base; if not, the 5-year URTH leadership is likely to persist. There is no obvious earnings-driven catalyst here, so the trade is primarily a macro/positioning bet rather than a company-specific one.